2006 survey 2013 survey   P*
Patients treated
for HCV infection
Patients NOT treated
for HCV infection
  Patients treated
for HCV infection
Patients NOT treated
for HCV infection
 
Number % Number % Total (%) Number % Number % Total (%)  
    416   342  
Age mean, years 43.6 43.3 43.6  49.5 48.9 49.2  <0.001
Gender
Male 163 74 109 67 272 (71)  140 70 81 66 221 (68)  0.46
Female 58 26 53 33 111 (29)  63  30  42  34  105 (32)  0.27
Geographic origin
Europe 188 85 122 75 310 (81)  139  81 79 77  218 (80)  0.52
Non Europe 33   41   74 (19)  33  19  23  23  56 (20)  0.11
Mode of infection transmission
Injection drug use 179 79 131 80 310 (77)  141  63  84 60  225 (62)  0.28
Heterosexual activity 22 10 18 11 40 (10)  27  12  26  19  53 (15)  0.83
Homosexual activity 19 8 7 4 26 (6)  30  13  16  12  46 (13)  0.60
Transfusion 5 2 3 2 8 (2)  15  7  4  3  19 (5) 0.63
Hemophilia 5 2 - - 5 (1)  8  4  3  2  11 (3) 0.51
Unknown 5 2 10 6 15 (4)  3  1  6  4  9 (2) 1.00
HIV viral load
Undetectable 170 76 96 60 266 (69)  177 86  96 75 273 (82) 0.86
<105 copies/ml 36 16 34 21 70 (18)  23  11  25  20  48 (14) 0.85
 105-106copies/ml 15 7 26 16 41 (11)  5  2  7  5  12 (4) 0.75
>106 copies/ml 2 1 5 3 7 (2)  1  1  0  0  1 (-) 0.38
CD4/ml
<200 16 7 33 20 49 (13)  18  8  19  15 37 (11) 0.18
200-349 69 31 46 28 115 (30)  37  18  27  21  64 (19) 0.87
 350-500  70 32 40 25 110 (29)  39  19  25  19  64 (19) 0.77
>500 66 30 44 27 110 (28)  116  55  58  45  174 (51) 0.26
Table 1: Main demographic and HIV characteristics of HIV-HCV co-infected patients, in those who had received HCV treatment and those who had never been treated in the 2006 and 2013 surveys. *P corresponds to the comparison between 2006 and 2013 surveys.